Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

2,121 Followers

Aurinia Pharmaceuticals (AUPH) Ownership Overview

11.26% Insiders

4.47% Mutual Funds

1.25% Other Institutional Investors

6.98% ETFs

76.04% Public Companies and

Individual Investors

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 12.70% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 76.04% is owned by Public Companies and Individual Investors.

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 5.72% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 6.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Aug 05, 2025	Kevin Tang	xxxxxxxxxxxxx	$13590000
Aug 05, 2025	Greg Keenan	xxxxxxxxxxxxx	$210000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
11,329,500	Insider	8.52%	184,047,728
5,309,762	Institution	3.99%	86,257,084
1,866,703	Institution	1.40%	30,324,590
1,744,866	Insider	1.31%	28,345,348
1,241,492	Institution	0.93%	20,168,038
1,240,831	Institution	0.93%	20,157,300
730,909	Institution	0.55%	11,873,617
710,464	Institution	0.53%	11,541,488
662,900	Insider	0.50%	10,768,811
556,703	Insider	0.42%	9,043,640

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,866,703	Institution	1.40%	30,324,590
1,240,831	Institution	0.93%	20,157,300
710,464	Institution	0.53%	11,541,488
422,016	Institution	0.32%	6,855,650
336,741	Institution	0.25%	5,470,358
105,000	Institution	0.08%	1,705,725
96,907	Institution	0.07%	1,574,254
92,212	Institution	0.07%	1,497,984
86,232	Institution	0.06%	1,400,839
80,526	Institution	0.06%	1,308,145

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,859,283	Institution	2.15%	45,090,893
iShares Russell 2000 Growth ETF	980,533	Institution	0.74%	15,463,005
iShares Biotechnology ETF	869,388	Institution	0.65%	13,710,249
Vanguard Russell 2000 ETF	587,659	Institution	0.44%	8,709,106
Janus Henderson Small/Mid Cap Growth Alpha ETF	539,369	Institution	0.41%	8,279,314
Vanguard Health Care ETF	335,388	Institution	0.25%	4,970,450
Fidelity Enhanced Small Cap ETF	300,268	Institution	0.23%	4,609,114
Avantis U.S Small Cap Equity ETF	243,388	Institution	0.18%	3,838,229
Janus Henderson Small Cap Growth Alpha ETF	191,540	Institution	0.14%	2,940,139
Principal U.S. Small-Cap Multi-Factor ETF	117,734	Institution	0.09%	1,856,665

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?

According to the latest TipRanks data, approximately 1.25% of the company's stock is held by institutional investors, 11.26% is held by insiders, and 76.04% is held by retail investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.25% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 76.04% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.

Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?

Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.